(HealthDay)—For patients with atrial fibrillation, decline in renal function is significantly greater with warfarin versus dabigatran etexilate (DE), according to a study published in the June 16 issue of the Journal of ...
Jun 10, 2015
0
9
If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined.
May 29, 2015
0
29
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology (ASH), proposes ...
May 29, 2015
0
3
(HealthDay)—Obese patients taking the blood thinner warfarin appear to have almost twice the risk of severe stomach bleeding compared to their normal-weight counterparts, a new study suggests.
May 9, 2015
0
66
In a study published in The Lancet on March 10, researchers from Brigham and Women's Hospital (BWH) report that patients with a genetic sensitivity to warfarin - the most widely used anticoagulant for preventing blood clots ...
Mar 10, 2015
0
29
Many community pharmacists can now manage anticoagulant levels for people, using testing and evaluation done at the pharmacy.
Oct 9, 2014
0
0
Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid ...
Aug 19, 2014
0
0
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia ...
May 9, 2014
0
1
New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings. A new article published in BJS (British Journal ...
Apr 29, 2014
0
0
Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than ...
Mar 4, 2014
0
0
